Rexahn Pharmaceuticals, Inc. (RNN)


NYSE MKT - NYSE MKT Real Time Price. Currency in USD
0.25-0.01 (-3.06%)
At close: 4:00 PM EDT
People also watch:
MSTXAEZSINOIMUCGALE
Interactive chart
  • 1d
  • 5d
  • 1m
  • 6m
  • YTD
  • 1y
  • 2y
  • 5y
  • 10y
  • Max
1d
Open0.26
Prev Close0.26
Bid0.23 x 200
Ask0.33 x 2900
Day's Range0.25 - 0.26
52wk Range0.24 - 0.65
1y Target EstN/A
Market Cap53.35M
P/E Ratio (ttm)-3.85
Beta-1.03
Volume390,063
Avg Vol (3m)626,836
Dividend & YieldN/A (N/A)
Earnings DateN/A
Trade prices are not sourced from all markets
  • Associated Press21 days ago

    Rexahn reports 2Q loss

    The Rockville, Maryland-based company said it had a loss of 1 cent per share. Losses, adjusted for non-recurring gains, were 2 cents per share. The company's shares closed at 27 cents. A year ago, they ...

  • GlobeNewswire21 days ago

    Rexahn Pharmaceuticals Reports Second Quarter 2016 Financial and Operational Results

    ROCKVILLE, Md., Aug. 08, 2016-- Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, today announced financial results ...

  • GlobeNewswire2 months ago

    Rexahn Pharmaceuticals Strengthens Leadership Team

    ROCKVILLE, Md., July 11, 2016-- Rexahn Pharmaceuticals, Inc., a clinical stage biopharmaceutical company developing best-in-class therapeutics for the treatment of cancer, today announced the appointment ...